Canadian women's health news
News
Treatment approvals, price changes, and coverage updates affecting women's health costs in Canada.
BC Plan NP Covers MHT at $0 Since March 1, 2026: What's Listed
BC's National Pharmacare Plan NP fully covers many menopausal hormone therapy products since March 1, 2026, with $0 medication and dispensing fees for MSP enrollees.
CPhA Flags Estrogen Patch, Premarin Vaginal Cream Supply Gaps
CPhA lists estrogen patches and Premarin vaginal cream among Canadian supply challenges as hormone APIs remain concentrated in China and India sourcing.
Health Canada Cites 262-Day Median Submission Gap vs US
Health Canada responds in JOGC to women's health access concerns, citing a 262-day median submission gap versus the US for new active substances in 2024.
Canada Registry Logs 92 Estradiol Shortages Since 2017
Drug Shortages Canada has recorded 92 shortages and 4 discontinuations of estradiol products since 2017, spanning patches, pills, rings, gels and creams.
US Lawmakers Petition FDA on Estradiol Patch Shortage
US House Democrats and physicians have petitioned the FDA to formally declare an estradiol patch shortage as prescriptions jumped from 594,000 to 1.6 million monthly.
Hormone Shortages Average 1,201 Days, Data Shows
Published data shows hormone drug shortages average 1,201 days, with API sourcing concentrated in China and India — context for Canadian MHT supply gaps.
Menopause Foundation Guide Flags Cost Questions at Virtual Clinics
The Menopause Foundation of Canada released a guide urging women to ask virtual and private menopause clinics about qualifications, costs, and compounded products.
Three Active Estradiol Shortages Listed on Canadian Registry
Health Product Shortages Canada lists three active estradiol shortages as of August 24, 2026: Lupin-Estradiol 2mg tablets, Estalis 140/50 patch, and Estradot 100 patch.
Menopause Hormone Shortage Sits Outside Health Canada Tier 3 List
Canada's current menopause hormone therapy supply issues affecting patches and Premarin vaginal cream have not been designated Tier 3 by Health Canada as of August 2026.
Estrogen Patch Shortage Hits B.C. as PharmaCare Coverage Expands
B.C. reports an estrogen patch shortage as menopausal hormone therapy became fully covered under PharmaCare on March 1, 2026, with Estradot supply constrained.
WomensHealthPrices.ca launches a news section for price and coverage changes
WomensHealthPrices.ca now reports news on Canadian women's health medication pricing: price changes, regulatory decisions, coverage updates, and industry moves.
Looking for current pharmacy prices?
Compare women's health medication prices across Canada